Infliximab for the treatment of hidradenitis suppurativa.
We describe a patient with hidradenitis suppurativa whose lesions responded to the administration of infliximab for suspected Crohn's disease.
Lebwohl
Benjamin
B
Columbia College of Physicians and Surgeons, New York, NY, USA.
Sapadin
Allen N
AN
D000152:Acne Vulgaris / Q000209:etiology / Q000473:pathology; D000328:Adult; D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000627:therapeutic use*; D002081:Buttocks; D003424:Crohn Disease / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy*; D003937:Diagnosis, Differential; D005765:Gastrointestinal Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D017497:Hidradenitis Suppurativa / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy*; D006801:Humans; D000069285:Infliximab; D008297:Male; D012883:Skin Ulcer / Q000209:etiology / Q000473:pathology
D000911:Antibodies, Monoclonal; D005765:Gastrointestinal Agents; D000069285:Infliximab